5T4-5T4-CD3

N/A

Report date: 2026/03/19 16:53:36

Base Information

Drug Name5T4-5T4-CD3

Drug Alias NameTB-5535T4-5T4-CD3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionT cell surface glycoprotein CD3 inhibitorsTrophoblast glycoprotein modulators

TargetsT cell surface glycoprotein CD3Trophoblast glycoprotein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiotecnol Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiotecnol Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A